Chronic Lymphocytic Leukemia

Showing NaN - NaN of 25

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (drug, other, biological)

Active, not recruiting
  • Anemia
  • +2 more
  • Birmingham, Alabama
  • +795 more
Jan 28, 2023

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +11 more
  • Zilovertamab vedotin
  • Duarte, California
  • +13 more
Jan 12, 2023

Atrial Fibrillation, Supraventricular Arrhythmia, Ventricular Arrhythmias and Cardiac Arrest Trial in New Hyde Park (Medtronic

Recruiting
  • Atrial Fibrillation
  • +4 more
  • Medtronic LINQ-2 Insertable Cardiac Monitor (ILR)
  • New Hyde Park, New York
    Northwell (Northshore University/Long Island Jewish Hospitals)
Dec 1, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Boston, Massachusetts
  • +11 more
Nov 23, 2022

Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (tafasitamab, parsaclisib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Non Hodgkin Lymphoma
  • Birmingham, Alabama
  • +49 more
Sep 21, 2022

Small Lymphocytic Lymphoma, Chronic Lymphocytic Leukemia Trial in Australia, United States (ABT-199, Rituximab)

Completed
  • Small Lymphocytic Lymphoma
  • Chronic Lymphocytic Leukemia
  • La Jolla, California
  • +5 more
Jul 11, 2022

Chronic Lymphocytic Leukemia Trial in Worldwide (ABT-263)

Completed
  • Chronic Lymphocytic Leukemia
  • La Jolla, California
  • +9 more
Jul 8, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Post-Chlorambucil Therapy Follow-up, Ibrutinib,

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Post-Chlorambucil Therapy Follow-up
  • +4 more
  • Duarte, California
  • +106 more
Aug 6, 2021

Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (Idelalisib,

Completed
  • Indolent Non-Hodgkin's Lymphoma
  • +2 more
  • Huntsville, Alabama
  • +10 more
Feb 22, 2021

Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Rituximab, Bendamustine)

Completed
  • Chronic Lymphocytic Leukemia
  • Huntsville, Alabama
  • +105 more
Mar 2, 2020

Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin Trial in United States (Idelalisib)

Terminated
  • Chronic Lymphocytic Leukemia
  • Lymphoma, Non-Hodgkin
  • Huntsville, Alabama
  • +17 more
Aug 22, 2019

Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib)

Terminated
  • Chronic Lymphocytic Leukemia
  • Huntsville, Alabama
  • +44 more
Aug 12, 2019

Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Rituximab, Placebo to match idelalisib)

Completed
  • Chronic Lymphocytic Leukemia
  • Huntsville, Alabama
  • +71 more
May 1, 2019

Collecting and Storing Malignant, Borderline Malignant

Completed
  • Acute Undifferentiated Leukemia
  • +13 more
  • Cytology Specimen Collection Procedure
  • Birmingham, Alabama
  • +191 more
Jul 17, 2018

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Ibrutinib, Chlorambucil)

Completed
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Duarte, California
  • +107 more
Nov 27, 2017

Chronic Lymphocytic Leukemia Trial in New Hyde Park (Campath)

Terminated
  • Chronic Lymphocytic Leukemia
  • New Hyde Park, New York
    Long Island Jewish Medical Center
Sep 16, 2015

Chronic Lymphocytic Leukemia Trial in United States (Talabostat mesylate (PT-100) tablets, Rituximab)

Completed
  • Chronic Lymphocytic Leukemia
  • Little Rock, Arkansas
  • +18 more
Mar 24, 2015

Chronic Lymphocytic Leukemia Trial in United States (IDEC-152)

Completed
  • Chronic Lymphocytic Leukemia
  • La Jolla, California
  • +6 more
Sep 12, 2013

Chronic Lymphocytic Leukemia Trial in New Hyde Park, Columbus, Nashville (Dasatinib, Combination of Bendamustine + Dasatinib)

Withdrawn
  • Chronic Lymphocytic Leukemia
  • Dasatinib
  • Combination of Bendamustine + Dasatinib
  • New Hyde Park, New York
  • +2 more
Jul 19, 2013

Chronic Lymphocytic Leukemia Trial in Washington, Buffalo, New Hyde Park (Oblimersen-rituximab-fludarabine)

Completed
  • Chronic Lymphocytic Leukemia
  • Washington, District of Columbia
  • +2 more
Nov 4, 2011

Kinetic Biomarker for Chronic Lymphocytic Leukemia Prognosis

Completed
  • Chronic Lymphocytic Leukemia
    • San Diego, California
    • +4 more
    Feb 25, 2011

    Chronic Lymphocytic Leukemia, CLL, Untreated Trial in United States (Lenalidomide and Rituximab)

    Unknown status
    • Chronic Lymphocytic Leukemia
    • +5 more
    • Lenalidomide and Rituximab
    • La Jolla, California
    • +4 more
    Sep 8, 2010

    Chronic Lymphocytic Leukemia, CLL Trial in New Hyde Park, Houston, San Antonio (Oblimerson sodium, G3139)

    Completed
    • Chronic Lymphocytic Leukemia
    • CLL
    • Oblimerson sodium, G3139
    • New Hyde Park, New York
    • +2 more
    Nov 10, 2009

    Chronic Lymphocytic Leukemia Trial in Palo Alto, New Hyde Park (Iodine-131 Anti-B1 Antibody)

    Unknown status
    • Chronic Lymphocytic Leukemia
    • Iodine-131 Anti-B1 Antibody
    • Palo Alto, California
    • +1 more
    Jun 23, 2005